HRMY
USDHarmony Biosciences Holdings Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$29.250
Kõrge
$30.890
Madal
$27.660
Maht
1.44M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.8B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.82M
Börs
NGM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
WAKIX® (pitolisant) Franchise Delivers Net Revenue of $239M in Q3 2025 (+29% YoY Growth) Record Increase in Average Number of Patients of Approximately 500 to Achieve 8,100 Average Patients in Q3 2025 Strong Cash
Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) today announced preliminary results for Q3 2025, highlighted by the following: WAKIX® (pitolisant) franchise delivered net revenue of approximately $239M in Q3
Seotud aktsiad
HBANL
Huntington Bancshares Incorporated Depositary Shares Each Representing a 1/40th Interest in a Share of 6.875% Series J Non-Cumulative Perpetual Preferred Stock
FSFG
First Savings Financial Group Inc.
SXTPW
60 Degrees Pharmaceuticals Inc. Warrant
BYM
Blackrock Municipal Income Quality Trust Common Shares of Beneficial Interest
NPK
National Presto Industries Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.